Pharma Journalist -

Ligand Pharmaceuticals Incorporated announces it will receive $10 million from a contractually specified royalty rate buy-down following the sale by CorMatrix Cardiovascular, Inc. of…
Read More...

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo, Japan-based Eisai Co., Ltd., and Johns Hopkins University announced today that they have extended their drug discovery…
Read More...

Synthetic Genomics and Advaxis announced that they have completed development and deployment of the first current good manufacturing practice (cGMP) synthetic biology facility for the…
Read More...

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide license agreement with Menlo Park, California-based xCella Biosciences, Inc. Under the license, xCella will…
Read More...

New research conducted by scientists at the University of Sheffield into a drug candidate which could help to delay the onset of motor neurone disease has shown encouraging early…
Read More...

AstraZeneca announced that, effective 1 June 2017, the Board has appointed Professor Nazneen Rahman as a Non-Executive Director of AstraZeneca PLC. On appointment, Professor Rahman also…
Read More...

TaiGen Biotechnology has submitted a New Drug Application (NDA) for Taigexyn (Nemonoxacin)intravenous formulation to China Food and Drug Administration (CFDA). Taigexyn is a novel…
Read More...

BioPharma Services has successfully completed 3 inspections this month by the US FDA, with concurrent audits at both research centers in Toronto, Canada, and Columbia, Missouri. Over…
Read More...

Bluebee and MediSapiens enters a partnership to provide customers with tailored end-to-end analytical solutions for Next Generation Sequencing (NGS) data. Sequencing technology is…
Read More...

Compugen Ltd board of directors has appointed Michal Preminger (PhD, MBA, Executive Director at Harvard University Office of Technology Development's Harvard Medical School site) as…
Read More...